BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12013870)

  • 1. [NARP].
    Yamagata T; Momoi MY
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():298-301. PubMed ID: 12013870
    [No Abstract]   [Full Text] [Related]  

  • 2. [NARP (neurogenic muscle weakness, ataxia and retinitis pigmentosa)].
    Goto Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):164-5. PubMed ID: 11596355
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) with a T-to-C point mutation at nt 8993 of mitochondrial DNA].
    Mitani M; Jinnai K; Takahashi K; Koide R; Tsuji S
    Rinsho Shinkeigaku; 2000 Jun; 40(6):600-4. PubMed ID: 11086401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NARP syndrome and adult-onset generalised seizures.
    Keränen T; Kuusisto H
    Epileptic Disord; 2006 Sep; 8(3):200-3. PubMed ID: 16987741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia.
    Parfait B; de Lonlay P; von Kleist-Retzow JC; Cormier-Daire V; Chrétien D; Rötig A; Rabier D; Saudubray JM; Rustin P; Munnich A
    Eur J Pediatr; 1999 Jan; 158(1):55-8. PubMed ID: 9950309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NARP-MILS syndrome caused by 8993 T>G mitochondrial DNA mutation: a clinical, genetic and neuropathological study.
    Rojo A; Campos Y; Sánchez JM; Bonaventura I; Aguilar M; García A; González L; Rey MJ; Arenas J; Olivé M; Ferrer I
    Acta Neuropathol; 2006 Jun; 111(6):610-6. PubMed ID: 16525806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA.
    White SL; Shanske S; Biros I; Warwick L; Dahl HM; Thorburn DR; Di Mauro S
    Prenat Diagn; 1999 Dec; 19(12):1165-8. PubMed ID: 10590437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein.
    López-Gallardo E; Solano A; Herrero-Martín MD; Martínez-Romero I; Castaño-Pérez MD; Andreu AL; Herrera A; López-Pérez MJ; Ruiz-Pesini E; Montoya J
    J Med Genet; 2009 Jan; 46(1):64-7. PubMed ID: 19124644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NARP syndrome--a less known mitochondrial disease].
    Kuusisto H; Simola KO; Keränen T
    Duodecim; 2003; 119(16):1563-6. PubMed ID: 14535029
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of neurologic muscle weakness, ataxia, and retinitis pigmentosa (NARP) syndrome with a novel mitochondrial mutation m.8729 G>A].
    Miyawaki T; Koto S; Ishihara H; Goto Y; Nishino I; Kanda F; Toda T
    Rinsho Shinkeigaku; 2015; 55(2):91-5. PubMed ID: 25746071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2 bp deletion in the mitochondrial ATP 6 gene responsible for the NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrome.
    Mordel P; Schaeffer S; Dupas Q; Laville MA; Gérard M; Chapon F; Allouche S
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):133-137. PubMed ID: 29054413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial mtDNA T8993C transition causing both the NARP and the MILS phenotype in the same generation. A morphological, genetic and spectroscopic study.
    Sciacco M; Prelle A; D'Adda E; Lamperti C; Bordoni A; Rango M; Crimi M; Comi GP; Bresolin N; Moggio M
    J Neurol; 2003 Dec; 250(12):1498-500. PubMed ID: 14673588
    [No Abstract]   [Full Text] [Related]  

  • 13. [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families].
    Tesarová M; Hansíková H; Hlavatá A; Klement P; Houst'ková H; Houstĕk J; Zeman J
    Cas Lek Cesk; 2002 Aug; 141(17):551-4. PubMed ID: 12404959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a mitochondrial genetic defect on capacitative calcium entry and mitochondrial organization in the osteosarcoma cells.
    Szczepanowska J; Zabłocki K; Duszyński J
    FEBS Lett; 2004 Dec; 578(3):316-22. PubMed ID: 15589839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load.
    Enns GM; Bai RK; Beck AE; Wong LJ
    Mol Genet Metab; 2006 Aug; 88(4):364-71. PubMed ID: 16546428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dementia/ataxia/deafness/myoclonus/retinopathy].
    Ohkoshi N
    Ryoikibetsu Shokogun Shirizu; 2001; (36):193-7. PubMed ID: 11596368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dementia/ataxia/deafness/myoclonus/retinopathy].
    Ohkoshi N
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():344-8. PubMed ID: 12013882
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemiatrophy, mental retardation, retinitis pigmentosa, vestibular disfunctions, myopathy].
    Sato M; Ohguro H
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():667-9. PubMed ID: 12013969
    [No Abstract]   [Full Text] [Related]  

  • 19. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA.
    Geromel V; Kadhom N; Cebalos-Picot I; Ouari O; Polidori A; Munnich A; Rötig A; Rustin P
    Hum Mol Genet; 2001 May; 10(11):1221-8. PubMed ID: 11371515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [May-white syndrome (myoclonus, ataxia, deafness)].
    Sekijima Y; Ikeda S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():392-7. PubMed ID: 12013895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.